Advances in biosensing: The CRISPR/Cas system as a new powerful tool for the detection of nucleic acids

J Pharm Biomed Anal. 2021 Jan 5:192:113645. doi: 10.1016/j.jpba.2020.113645. Epub 2020 Sep 24.

Abstract

A main challenge in the development of biosensing devices for the identification and quantification of nucleic acids is to avoid the amplification of the genetic material from the sample by polymerase chain reaction (PCR), which is at present necessary to enhance sensitivity and selectivity of assays. PCR has undoubtedly revolutionized genetic analyses, but it requires careful purification procedures that are not easily implemented in point of care (POC) devices. In recent years, a new strategy for nucleic acid detection based on clustered regularly interspaced short palindromic repeats (CRISPR) and associated protein systems (Cas) seems to offer unprecedented possibilities. The coupling of the CRISPR/Cas system with recent isothermal amplification methods is fostering the development of innovative optical and electrochemical POC devices. In this review, the mechanisms of action of several new CRISRP/Cas systems are reported together with their use in biosensing of nucleic acids.

Keywords: Biosensing; CRISPR/Cas; Electrochemical sensor; Molecular diagnostic; Nucleic acids; Optical sensor.

Publication types

  • Review

MeSH terms

  • CRISPR-Cas Systems / genetics
  • Clustered Regularly Interspaced Short Palindromic Repeats*
  • Nucleic Acids* / genetics
  • Point-of-Care Systems

Substances

  • Nucleic Acids